Skip to main content
NOVELIX PHARMACEUTICALS LIMITED logo

NOVELIX PHARMACEUTICALS LIMITED — Investor Relations & Filings

Ticker · 536565 ISIN · INE314I01036 LEI · 8945002HROSD4VUIYY08 BSE.NS Manufacturing
Open in API
Filings indexed 15 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country IN India
Listing BSE.NS 536565

About NOVELIX PHARMACEUTICALS LIMITED

https://novelixpharma.com/

Novelix Pharmaceuticals Limited specializes in the research, development, and large-scale manufacturing of pharmaceutical formulations and active ingredients. The company’s portfolio encompasses a broad spectrum of therapeutic segments, including cardiology, gastroenterology, and metabolic health. It focuses on the production of high-quality generic medications, utilizing sophisticated chemical synthesis and formulation technologies to ensure bioequivalence and safety. Core competencies include the development of diverse dosage forms such as oral solids, liquids, and parenteral preparations. By integrating rigorous quality management systems and advanced analytical testing, the organization maintains a commitment to delivering standardized healthcare solutions aimed at improving clinical outcomes across various medical disciplines.

Recent filings

Filing Released Lang Actions
Submission of Intimation of Allotment of equity shares to promoters and promoter group.
Regulatory Filings
2026-06-02 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Srindhi Fine Chemicals LLP
Major Shareholding Notification Classification · 90% confidence The document is a regulatory disclosure under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, detailing the allotment of shares to promoters and changes in shareholding percentages before and after acquisition. It notifies a substantial acquisition/crossing of shareholding thresholds. This matches the definition of a Major Shareholding Notification (code MRQ).
2026-06-02 English
Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/06/2026 ,inter alia, to consider and approve 1. To consider and ....
Regulatory Filings Classification · 85% confidence The document is an intimation under SEBI Listing Regulations to the stock exchange regarding a forthcoming Board meeting, including agenda items and trading window closure. It is not announcing any actual board appointment or change, nor is it publishing a financial report, but is a regulatory notice. This best fits the “Regulatory Filings” (RNS) category as a general regulatory announcement.
2026-06-01 English
Trading window closure intimation.
Regulatory Filings Classification · 85% confidence The document is a regulatory compliance notice addressed to the stock exchange informing about the closure of the trading window under SEBI’s Insider Trading Regulations ahead of a board meeting. It does not contain financial results, board changes, capital approvals, or voting results. It is an announcement of regulatory action rather than a standalone report or form, so it best fits the fallback category “Regulatory Filings” (RNS).
2026-06-01 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vupparapalli Reddy & Other
Major Shareholding Notification Classification · 88% confidence The document is an intimation/disclosure under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, detailing the acquisition/allotment of equity shares by a promoter via conversion of warrants, including shareholding percentages before and after. This aligns with a notification of changes in significant share ownership (crossing thresholds). Therefore, it is classified as a Major Shareholding Notification.
2026-06-01 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gattu Gnana Prakash & Others
Major Shareholding Notification Classification · 90% confidence The document is an intimation/disclosure filed under Regulation 29 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, detailing the allotment and post-allotment shareholding of the promoters. This is a notification of changes in significant share ownership levels, matching the Major Shareholding Notification category.
2026-06-01 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.